Lithium fluoride thermoluminescence (TL) detectors, with different Li composition (Li-6 and Li-7) and various activators (LiF:Mg,Ti, LiF:Mg,Cu,P), are widely used for dosimetry in space. The primary radiation field in space is composed of fast electrons, protons and heavy charged particles (HCP). By its interaction with the structures of the spacecraft, this field may be modified inside the crew cabin. Therefore, calibration of TL detectors against a dose of gamma-rays is not sufficient for relating the TL readout to absorbed dose or to quantities relevant in radiation protection, without suitable correction. We introduce and calculate the detection efficiency, eta, relative to gamma-ray dose, of lithium fluoride detectors after proton and heavy charged particle (HCP) irradiation. We calculate eta for MCP-N (LiF:Mg,Cu,P) and for MTS-N (LiF:Mg,Ti) using microdosimetric models. The microdosimetric distributions used in these models (for HCP of charges between Z=1 to Z=8 and in the energy range between 0.3 MeV/amu and 20 MeV/amu) are calculated using an analytical model, based on the results of Monte Carlo simulated charged particle tracks using the MOCA-14 code. The ratio etaMCP-N/etaMTS-N for protons of stopping power (in water) below 10 keV/microm lies in the range between 0.65 and 1.0 and for HCP with Z>1--between 0.3 and 0.6. The stopping power of the particle is found not to be a unique parameter to scale the response of TL detectors. The combination of response of LiF:Mg,Cu,P and LiF:Mg,Cu,P detectors can be more suitable for a dose correction in space radiation fields.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1269/jrr.43.s59 | DOI Listing |
J Appl Clin Med Phys
November 2024
Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, Shanghai, China.
Background: Lung cancer poses a significant global health challenge. Adaptive radiotherapy (ART) addresses uncertainties due to lung tumor dynamics. We aimed to investigate a comprehensively and systematically validated offline ART regimen with high clinical feasibility for lung cancer.
View Article and Find Full Text PDFJ Appl Clin Med Phys
November 2024
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA.
Purpose: In vivo dosimetry is a common requirement to validate dose accuracy/uniformity in total body irradiation (TBI). Several detectors can be used for in vivo dosimetry, including thermoluminescent dosimeters (TLDs), diodes, ion chambers, optically stimulated luminescent dosimeters (OSLDs), and film. TLDs are well established for use in vivo but required expertise and clinical system availability may make them impractical for multifractionated TBI.
View Article and Find Full Text PDFRadiat Prot Dosimetry
December 2024
NuklindoLab, Research and Development Division, Plaza Ciputat Mas, 5A Ir. H. Juanda Street, Block B Kav P-Q, South Tangerang 15412, Indonesia.
The study aims to evaluate the energy response of the thermoluminescent dosemeter (TLD) CaSO4:Dy from high energy photon beams produced from medical linear accelerator. The test was performed on the polymethyl methacrylate phantom surface and at the depth of dose maximum with a source-to-surface distance of 100 cm and the radiation field size of 12 × 12 cm. The results were compared with the TLD response exposed to 60Co standard source.
View Article and Find Full Text PDFAppl Radiat Isot
December 2024
Instituto Nacional de Investigaciones Nucleares, Carretera México-Toluca S/N, La Marquesa, Ocoyoacac, Estado de México, 52750, Mexico.
The thermoluminescent (TL) response of MgO doped with different rare earths was investigated. The TL material was synthesized by the solution combustion method and sintered at 1173 K; the obtained powders were prepared in pellet form. Before irradiation, the dosimeters were annealed at 623 K for 30 min to eliminate any TL signal generated during their manufacture.
View Article and Find Full Text PDFBiomed Phys Eng Express
October 2024
Department of Radiation Oncology, Northwestern University, Chicago, IL, 60611, United States of America.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!